ZiP Diagnostics has been announced as one of the successful recipients of the Department of Industry, Science and Technology, Accelerating Commercialisation grants scheme, receiving $750,000 to establish manufacturing facilities for customised protein production and commercialisation of low cost, high sensitivity molecular diagnostic tests.
The Minister specifically identified two projects that had impressive health benefits and outstanding commercial potential. ZiP was one of these with the Minister stating “… the ZiP system promises to vastly reduce the amount of time required for infectious diseases results to be confirmed…”
Dr Jack Richards, ZiP Scientific Director, was very pleased to receive the grant, “This grant will provide ZiP with important funding to ramp-up our Collingwood production facility and to provide a unique domestic capability to produce low-cost novel point-of-care molecular diagnostics for infectious diseases, including COVID-19, for Australia and world markets."
Comments